Tom G. Vadaketh - 02 Mar 2023 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role: EVP, Chief Financial Officer
Signature: /s/ Brianna M. Cetrulo, attorney-in-fact
Issuer symbol: BHC
Transactions as of: 02 Mar 2023
Net transactions value: -$37,009
Form type: 4
Filing time: 06 Mar 2023, 15:48:01 UTC
Previous filing: 04 Jan 2023
Next filing: 21 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHC	Common Shares, No Par Value	Tax liability	$37,009	-4,001	-0.85%	$9.25	466,203	02 Mar 2023	Direct	F1
transaction	BHC	Common Shares, No Par Value	Award	$0	+142,678	+31%	$0.000000	608,881	02 Mar 2023	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BHC	Non-Qualified Stock Options (right to purchase)	Award	$0	+123,177		$0.000000	123,177	02 Mar 2023	Common Shares, No Par Value	123,177	$9.25	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F2	Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
F3	The options vest in equal installments on each of the first three anniversaries of the date of grant.